Iqbal J Hussain insider trades: Centessa Pharmaceuticals (CNTA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Iqbal reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | CNTA | ↓ Sell | 39,961 | $25.15 | $1.0M | Direct | Feb 3, 2026 (1d) |
| Nov 17, 2025 | CNTA | ↓ Sell | 6,000 | $27.64 | $166K | Direct | Nov 18, 2025 (1d) |
| Oct 15, 2025 | CNTA | ↓ Sell | 6,000 | $22.41 | $134K | Direct | Oct 16, 2025 (1d) |
| Sep 15, 2025 | CNTA | ↓ Sell | 6,000 | $21.85 | $131K | Direct | Sep 15, 2025 (0d) |
| Sep 10, 2025 | CNTA | ↓ Sell | 40,000 | $21.00 | $840K | Direct | Sep 11, 2025 (1d) |
| Aug 15, 2025 | CNTA | ↓ Sell | 6,000 | $17.23 | $103K | Direct | Aug 15, 2025 (0d) |
| Jul 15, 2025 | CNTA | ↓ Sell | 6,000 | $14.93 | $90K | Direct | Jul 17, 2025 (2d) |
| Jun 24, 2025 | CNTA | ↓ Sell | 12,000 | $14.02 | $168K | Direct | Jun 25, 2025 (1d) |
| May 1, 2025 | CNTA | ↓ Sell | 311 | $14.00 | $4K | Direct | May 2, 2025 (1d) |
| Apr 28, 2025 | CNTA | ↓ Sell | 5,689 | $14.00 | $80K | Direct | Apr 29, 2025 (1d) |
| Mar 17, 2025 | CNTA | ↓ Sell10b5-1 | 6,000 | $16.45 | $99K | Direct | Mar 19, 2025 (2d) |
| Feb 18, 2025 | CNTA | ↓ Sell | 6,000 | $16.18 | $97K | Direct | Feb 19, 2025 (1d) |
| Jan 15, 2025 | CNTA | ↓ Sell | 6,000 | $15.29 | $92K | Direct | Jan 17, 2025 (2d) |
| Dec 16, 2024 | CNTA | ↓ Sell | 77,705 | $16.39 | $1.3M | Direct | Dec 17, 2024 (1d) |
| Oct 3, 2022 | CNTA | ↓ Sell | 8,288 | $4.00 | $33K | Direct | Oct 4, 2022 (1d) |
| Jun 2, 2021 | CNTA | ↑ Buy | 5,500 | $20.00 | $110K | By spouse | Jun 4, 2021 (2d) |
| Jun 2, 2021 | CNTA | ↑ Buy | 3,000 | $20.00 | $60K | Direct | Jun 4, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CNTA insiders
Open-market trades in the last 12 months
About Iqbal J Hussain's insider trades
Iqbal J Hussain is Chief Legal Officer at Centessa Pharmaceuticals (CNTA). Since Jun 2, 2021, Iqbal has reported 2 open-market purchases worth $170K and 15 sales worth $4.3M on SEC Form 4. In the last 12 months: 2 sales ($1.2M).
1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (13 filings), option exercises (13 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.